Table 2 Logistic regression of clinical pathological characteristics and ALDH2 expression.

From: Exploring ALDH2 expression and immune infiltration in HNSC and its correlation of prognosis with gender or alcohol intake

Clinical Characteristics

Total (N)

OR

95% CI

P value

Clinical stage

Ā Stage II vs. Stage I

114

0.736

0.254–1.996

0.555

Ā Stage III vs. Stage I

121

0.519

0.180–1.396

0.202

Ā Stage IV vs. Stage I

291

0.566

0.205–1.452

0.247

T stage

Ā T2 vs. T1

177

0.836

0.379–1.793

0.649

Ā T3 vs. T1

164

0.485

0.218–1.048

0.069

Ā T4 vs. T1

212

0.643

0.295–1.358

0.253

N stage

Ā N1 vs. N0

319

0.881

0.530–1.467

0.624

Ā N2 vs. N0

393

0.647

0.430–0.971

0.036

Ā N3 vs. N0

246

0.133

0.007–0.794

0.064

M stage

Ā M1 vs. M0

477

1.475

0.242–11.273

0.672

Gender

Ā Male vs. Female

502

0.850

0.571–1.262

0.420

Age

Ā > 65Ā vs. ≤ 65

501

1.041

0.733–1.478

0.822